Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort

American Journal of Psychiatry

Volumn 155, Issue 6, 1998, Pages 761-767

  Abi Dargham, Anissa ^a   Gil, Roberto ^b   Krystal, John ^b   Baldwin, Ronald M ^b   Seibyl, John P ^b   Bowers, Malcom ^b   Van Dyck, Christopher H ^b   Charney, Dennis S ^b   Innis, Robert B ^b   Laruelle, Marc ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; META ANALYSIS; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIOECONOMICS;

ADULT; AMPHETAMINE; BENZAMIDES; COHORT STUDIES; CORPUS STRIATUM; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRROLIDINES; RECEPTORS, DOPAMINE; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031799667     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 18F]N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboons. Synapse 1991; 9:195-207
2. 2 receptor in non-human primates. Synapse 1992; 10:177-184
3. Rung HE, Kasliwal R, Pan S, Kung M-P, Mach RH, Guo Y-Z: Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of R-(+)- and S-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benz amide. J Med Chem 1988; 31:1039-1043
4. Laruelle M, Iyer RN, Al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW: Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 1997; 25:1-14
5. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF, Innis RB: SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 1995; 36:1182-1190
6. Laruelle M, Abi-Dargham A, Van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB: Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93:9235-9240
7. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, deBartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D: Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 1997; 94:2569-2574
8. Hollingshead AB: Four-Factor Index of Social Status. New Haven, Conn, Yale Universjry, Department of Sociology, 1975
9. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
10. Gandelman MS, Baldwin RM, Zoghhi SS, Zea-Ponce Y, Innis RB: Evaluation of ultrafiltration for the free fraction determination of single photon emission computerized tomography (SPECT) radiotracers: β-CIT, IBF and iomazenil. J Pharm Sci 1994; 83:1014-1019
11. Bacopoulos NG, Heninger G, Roth RH: Effects of haloperidol and probenecid on plasma and CSF dopamine metabolites in the rhesus monkey (Macacca mulatta). Life Sci 1978; 23:1805-1812
12. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
13. Wong D, Gjedde A, Reith J, Grunder G, Szymanski S, Yokoi F, Hong C, Nestadt G, Neufeld K, Pearlson G, Tune L, Angrist B: Multiple lines of evidence for dopamine dysfunction in psychosis by imaging (abstract). Schizophr Res 1997; 24:183
14. Zetterstrom T, Sharp T, Marsden CA, Ungerstedt U: In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem 1983; 41:1769-1773
15. Zetterstrom T, Sharp T, Ungerstedt U: Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur J Pharmacol 1986; 132:1-9
16. Kuczenski R, Segal D: Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 1989; 9:2051-2065
17. 11C]raclopride. Arch Gen Psychiatry 1990; 47:213-219
18. 2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 1994; 51:116-123
19. Lipska B, Weinberger D: Cortical regulation of the mesolimbic dopamine system: implication for schizophrenia, in Limbic Motor Circuits and Neuropsychiatry. Edited by Kalivas PW, Barnes CD. Boca Raton, Fla, CRC Press, 1993, pp 329-349
20. Kolachana BS, Saunders RC, Bachevalier J, Weinberger DR: Abnormal prefrontal cortical regulation of striatal dopamine release after neonatal medial temporal-limbic lesions in rhesus monkeys. Abstracts of the Society for Neuroscience 1996; 22: 1974
21. Deutch AY: Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J Neural Transm 1993; 91:197-221